01 Stock Market
The U.S. major indexes closed as follows: Dow Jones up 0.22% at 53,463.05; S&P 500 up 0.21% at 7,707.98; NASDAQ up 0.16% at 26,331.09.
Stand-out movers reflected a dramatic biotech surge and mixed tech performance. Moderna (MRNA) soared 176.97% to $174.38 after winning a landmark FDA approval, by far the day’s biggest percentage gainer. Chipmaker Marvell Technology (MRVL) jumped 9.85% to $237.27, while electric-vehicle leader Tesla (TSLA) climbed 4.23% to $351.12. On the downside, semiconductor-linked ETFs and suppliers lagged: Direxion Daily SOXL fell 6.48% to $120.74 and Applied Optoelectronics (AAOI) declined 7.02% to $122.19. Tech titan Apple (AAPL) added 2.19% to $316.83, contrasting with a 0.99% slip in NVIDIA (NVDA) to $217.56.
02 Other Markets
The U.S. 10-year Treasury yield was unchanged, latest at 4.65%. USD/CNH fell 0.05%, at 6.78; USD/HKD fell 0.01%, at 7.84. U.S. Dollar Index rose 0.01%, at 98.81. WTI crude futures rose 0.11%, at $84.48 USD/bbl; COMEX gold futures rose 0.75%, at $4,579.30 USD/oz.
03 Top News
1. Fed Minutes Signal Rising Readiness for Future Rate Hike. Newly released records show several policymakers favored an immediate increase, and many said more tightening will be needed if inflation stays high. The stance underscores the Federal Reserve’s commitment to achieving its 2% inflation goal.
2. Treasury Boosts Long-Term Bond Buybacks, Pushing Yields Sharply Lower. The department will double repurchases of 10-, 20- and 30-year bonds to at least $4 billion per operation, calming a recent sell-off that had driven the 30-year yield to 19-year highs. Investors welcomed the move, sending major stock indexes modestly higher and lifting gold prices.
3. U.S. Public Debt Tops $40 Trillion, Sparking Fiscal-Crisis Warnings. Treasury data show federal obligations have more than doubled in under a decade, propelled by pandemic borrowing and structural deficits. Budget experts warn that without tax hikes or spending cuts, mounting interest costs could threaten economic stability.
4. Ultragenyx Secures First-Ever FDA Approval for Gene Therapy Treating GSDIa. The newly approved Genglycos targets a rare metabolic disorder affecting up to 2,500 U.S. patients and carries a $2.7 million list price. Shares of Ultragenyx rose about 7.5% in after-hours trading on expectations of significant revenue potential.
5. Coty Extends Turnaround With Strategic Review, Guides for Near-Term Sales Dip. Interim CEO Markus Strobel said the beauty group aims to finish evaluating its consumer division by year-end 2026 while focusing on prestige fragrances. Despite a wider quarterly loss, management forecasts improving performance after a transitional fiscal year.
6. Deere Prepares to Report Earnings Amid Sluggish Farm-Equipment Demand. Analysts anticipate fiscal 3Q earnings of $4.69 per share, roughly flat year-on-year, reflecting weaker crop prices and farmer spending. Investors look for updated 2026 profit guidance after recent sales declines.
7. Walmart Expected to Deliver Another Quarter of Solid Sales Growth. Consensus calls for 2Q revenue near $186.6 billion and a 3.8% same-store sales increase, with attention on the expansion of its membership program. Shares have fallen nearly 14% over three months, heightening focus on guidance.
8. Netflix Faces Trademark Lawsuit from Band Demon Hunter over ‘KPop Demon Hunters’ Tour. The Christian metal group claims the planned concert series tied to Netflix’s hit animated film could confuse consumers and dilute its brand. Netflix and promoter AEG have not yet commented on the California filing.
9. U.S.–Canada Trade Pact Nears Completion, Promising Tariff Relief for Farmers. President Trump said forthcoming terms would cut Canadian levies on American agricultural products to zero and reduce duties on select Canadian exports. The agreement aims to avert steep reciprocal tariffs threatened earlier in the summer.
10. Digital-Policy Reversal Looms as U.S.–Canada Talks Advance. The U.S. Trade Representative signaled “digital trade alignment,” prompting analysts to predict Ottawa will scrap former Prime Minister Trudeau’s online news law and abandon plans for a digital-services tax. The moves could reopen Canadian market access for U.S. tech platforms.
Sources: Reuters, Dow Jones, Tiger Newspress, MT Newswires Live, public market data
Disclaimer: This content is for reference only and does not constitute investment advice.
